Metasphere Labs Inc.
LABZ
CNSX
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -14.60K | 1.20K | 1.20K | 174.60K | 672.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -14.60K | 1.20K | 1.20K | 174.60K | 672.90K |
| Cost of Revenue | -13.80K | 1.20K | 1.20K | 40.50K | 132.10K |
| Gross Profit | -800.00 | 100.00 | 100.00 | 134.30K | 540.90K |
| SG&A Expenses | 442.60K | 453.70K | 562.50K | 711.80K | 811.70K |
| Depreciation & Amortization | -- | -- | -- | 32.70K | 62.70K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 442.60K | 468.80K | 593.00K | 820.50K | 1.04M |
| Operating Income | -457.10K | -467.40K | -591.60K | -645.80K | -369.00K |
| Income Before Tax | -506.50K | -517.90K | -655.40K | -1.20M | -892.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.51 | -0.52 | -0.66 | -1.20 | -0.89 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -506.50K | -517.90K | -655.40K | -1.20M | -892.50K |
| EBIT | -457.10K | -467.40K | -591.60K | -645.80K | -369.00K |
| EBITDA | -313.40K | -380.70K | -573.80K | -627.90K | -325.60K |
| EPS Basic | -0.05 | -0.05 | -0.07 | -0.14 | -0.11 |
| Normalized Basic EPS | -0.03 | -0.03 | -0.04 | -0.05 | -0.03 |
| EPS Diluted | -0.06 | -0.06 | -0.08 | -0.16 | -0.12 |
| Normalized Diluted EPS | -0.03 | -0.03 | -0.04 | -0.05 | -0.03 |
| Average Basic Shares Outstanding | 42.34M | 41.73M | 40.24M | 37.37M | 37.45M |
| Average Diluted Shares Outstanding | 42.34M | 41.73M | 40.24M | 37.37M | 41.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |